Literature DB >> 2185438

The pharmacokinetics of agents used to treat status epilepticus.

T R Browne1.   

Abstract

A thorough understanding of the pharmacologic properties of lipid-soluble drugs is essential when using these agents to treat status epilepticus. In addition to physiologic factors, such as blood pressure and cerebral blood flow, pharmacokinetic principles, including half-life, distribution, elimination, and volume of distribution (with special regard to an agent's lipid-solubility rating), should be applied. These factors, in toto, will influence the choice of drug, its loading dose, and its therapeutic dose.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185438

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Treatment of status epilepticus in children.

Authors:  M De Negri; M G Baglietto
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Ictal Interictal Continuum Patterns.

Authors:  Gamaleldin M Osman; Davi F Araújo; Carolina B Maciel
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

3.  Treatment options in the management of status epilepticus.

Authors:  Andrea O Rossetti
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

Review 4.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.